Tag: BioMed X Institute

The research of BioMed X team EPD - Early Intervention in Psychiatric Diseases - has shed light on the molecular mechanisms underlying white...

A new research team at XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound...

The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who can benefit from cancer immunotherapy. BioMed...

Researchers at the BioMed X Institute and the Universit?tsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in...

German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies. BioMed X announced today...

A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease. BioMed X,...

BioMed X inaugurates its new institute in the USA with a research project on complex ex vivo models of tissue inflammation in collaboration...